Nat Commun:METTL3通过m6A修饰介导APC的表达促进肿瘤的发生发展

2021-06-24 xiaozeng MedSci原创

结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用

结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用,而该通路主要调控细胞的增殖和分化。

既往研究显示,APC的功能丧失会导致β-catenin的异常稳定。反式激活的 β-catenin能够与TCF/LEF形成复合物,并激活许多重要的下游基因,如CCND1和MYC,最终促进肿瘤的发生发展。

结直肠癌中APC的突变率可达80%。相比之下,APC在如食道鳞状细胞癌(ESCC)在内的其他类型癌症中却很少发生突变。然而,目前并不清楚APC的表达水平是否受表观转录组水平的调控,以促进肿瘤的发生发展。

METTL3的表达上调与ESCC患者的低生存率相关

在该研究中,研究人员通过分析TCGA数据并分析200对ESCC标本及其邻近的正常组织,鉴定了METTL3(甲基转移酶样蛋白3)在肿瘤组织中高表达。m6A-RNA免疫沉淀实验发现,METTL3能够上调APC的m6A修饰水平,并招募YTHDF降解APC的mRNA。

METTL3促进ESCC发生发展的机制示意图

研究人员发现,降低APC的表达水平会上调β-catenin以及β-catenin介导的cyclin D1、c-Myc和PKM2的表达,进而增强有氧糖酵解作用、ESCC细胞的增殖和肿瘤的形成。此外,APC的表达水平下调与ESCC样本中METTL3的表达上调以及ESCC患者的不良预后相关。


总而言之,该研究结果揭示,METTL3/YTHDF介导的APC表观转录水平的下调能够通过上调Wnt/β-catenin通路,促进ESCC的发生发展。


原始出处:

Wang, W., Shao, F., Yang, X. et al. METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding. Nat Commun 12, 3803 (21 June 2021).

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
    2021-12-15 kcb077
  2. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
    2021-08-21 liuli5079
  3. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
    2022-04-23 一闲
  5. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
    2022-04-22 liye789132251
  6. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
    2021-11-20 liuxiaona
  7. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
    2021-06-28 1453df99m58暂无昵称

    结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
    2021-06-25 大郎该吃药了

    学习了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
    2021-06-25 lfcmxl
  10. [GetPortalCommentsPageByObjectIdResponse(id=1647776, encodeId=8c41164e776bb, content=<a href='/topic/show?id=ac501119586' target=_blank style='color:#2F92EE;'>#m6A#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11195, encryptionId=ac501119586, topicName=m6A)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e88323484130, createdName=kcb077, createdTime=Wed Dec 15 05:39:08 CST 2021, time=2021-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2088042, encodeId=dd0320880421c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Sat Aug 21 02:39:08 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030817, encodeId=69f5203081eb3, content=<a href='/topic/show?id=71353e8964f' target=_blank style='color:#2F92EE;'>#发生发展#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37896, encryptionId=71353e8964f, topicName=发生发展)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=346311, createdName=wgsun, createdTime=Fri Nov 12 18:39:08 CST 2021, time=2021-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1896859, encodeId=37c31896859aa, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11582, encryptionId=4a391158248, topicName=MET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 23 18:39:08 CST 2022, time=2022-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1885252, encodeId=9de2188525269, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Apr 22 17:39:08 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952290, encodeId=b16419522904d, content=<a href='/topic/show?id=d11d1162e58' target=_blank style='color:#2F92EE;'>#Mettl3#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11627, encryptionId=d11d1162e58, topicName=Mettl3)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cb3a261, createdName=liuxiaona, createdTime=Sat Nov 20 08:39:08 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977660, encodeId=7afe9e766031, content=结肠腺癌抑制基因(adenomatous polyposis coli,APC)被认为是一种关键的肿瘤抑制基因,其在抑制经典Wnt信号通路中起着至关重要的作用。, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd984965877, createdName=1453df99m58暂无昵称, createdTime=Mon Jun 28 18:43:39 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976844, encodeId=889a9e68447d, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210515/fdb40d331d654a408c5c21ba2cc99d8e/e9157a03ad7a4e8ca944ff70d9565fc7.jpg, createdBy=f6da5502104, createdName=大郎该吃药了, createdTime=Fri Jun 25 17:16:18 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1370397, encodeId=b15f13e0397d2, content=<a href='/topic/show?id=f75726283f' target=_blank style='color:#2F92EE;'>#APC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2628, encryptionId=f75726283f, topicName=APC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1569400, encodeId=3b4f156940015, content=<a href='/topic/show?id=1c562e42646' target=_blank style='color:#2F92EE;'>#修饰#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27426, encryptionId=1c562e42646, topicName=修饰)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29c615505859, createdName=zhangyxzsh, createdTime=Fri Jun 25 15:39:08 CST 2021, time=2021-06-25, status=1, ipAttribution=)]
    2021-06-25 zhangyxzsh

相关资讯

APC的作用及在结直肠癌中的治疗潜能

腺瘤性结肠息肉(APC)病基因是结直肠癌抑癌基因,可在胚系和体系水平出现异常调节。APC位于5q21-q22,含8535核酸,21外显子,编码310 kDa蛋白,含2843氨基酸,75%编码序列位于外显子15,是胚系和体突变最常发生部位。胚系突变致家族性腺瘤息肉病(FAP),是CRC主要易感事件,APC体突变见于>80%散发CRC,5q杂合性缺失(LOH)见于30%–40%的CRC。APC蛋白

Gastroenterology:血浆细胞是乳糜泻患者发炎肠组织中表达MHC更丰富的细胞

乳糜泻的发展被认为是CD4T细胞对具有特异性HLA-DQ单倍型的个体的肠粘膜中的脱酰胺谷蛋白肽的转谷氨酰胺酶依赖性反应。本项研究旨在了解这种粘膜免疫反应过程中的抗原呈递过程。

Blood:c-Myc单倍体剂量不足在HSC维持中的作用

近日,《血液》杂志上发表了一篇新研究,报道了c-Myc对造血作用的剂量效应及其在造血干细胞(HSC)和骨髓壁龛细胞中介导Wnt/b-catenin通路的独特作用。

J Clin Periodontol:自体血小板浓缩物对骨内缺损GTR/移植物联合治疗的影响

实验旨在研究有无额外应用自体血小板浓缩物(APC)对引导组织再生(GTR)治疗深部骨内缺损的长期临床结果。

Br J Cancer:APC缺失通过介导Wnt/β-catenin/PKM2通路诱导结直肠癌细胞的Warburg效应

相比于正常细胞,癌细胞表现出新陈代谢的改变、有氧糖酵解的增加和氧化磷酸化的减少。与氧气供应无关的葡萄糖摄取和乳酸生成增加,被称为有氧糖酵解或Warburg效应,是大多数癌细胞的主要特征。这种重编程的新